Loading
MB
Med BioGene Inc. Stock: price and insider trades · Canada
Med BioGene Inc.: what insiders have been doing
Med BioGene Inc. is a listed company. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for Med BioGene Inc. The previous disclosure was published on 18 February 2021.
The full history, which starts in 2016, counts 8 purchases against 3 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
19
Thresholds
n/a
Buy Volume
€8,024
8 ops. · all time
Sell Volume
€44,893
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 18 February 2021
Declarations19 total
300,000 shares@ CA$0.1457.1% of flowCommon SharesTSXSEDI:3681690
54,500 shares@ CA$0.2014.8% of flowCommon SharesTSXSEDI:3681694
80,000 shares@ CA$0.2021.7% of flowCommon SharesTSXSEDI:3681691
1,200,000 sharesCommon SharesTSXSEDI:3543176
49,000 shares@ CA$0.05100.0% of flowCommon SharesTSXSEDI:3428715
Canonical exit: 23 Dec 2019 (T+90)
1,200,000 shares@ CA$0.0599.6% of flowCommon SharesTSXSEDI:3386814
32,000 shares@ CA$0.0427.7% of flowCommon SharesTSXSEDI:3365354
Canonical exit: 14 Jul 2019 (T+90)
10,000 shares@ CA$0.048.7% of flowCommon SharesTSXSEDI:3365355
Canonical exit: 16 Jul 2019 (T+90)
10,000 shares@ CA$0.048.7% of flowCommon SharesTSXSEDI:3365356
Canonical exit: 25 Jul 2019 (T+90)
Common SharesTSXSEDI:3365353
13,500 sharesCommon SharesTSXSEDI:3101832
40,500 sharesCommon SharesTSXSEDI:3101657
648,000 sharesCommon SharesTSXSEDI:3101841
7,897,068 sharesCommon SharesTSXSEDI:3101838
150,000 shares@ CA$0.035100.0% of flowCommon SharesTSXSEDI:2959361
Canonical exit: 18 May 2017 (T+90)
8,000 shares@ CA$0.02910.4% of flowCommon SharesTSXSEDI:2913278
Canonical exit: 14 Feb 2017 (T+90)
890,000 sharesCommon SharesTSXSEDI:2837325
3,190 shares@ CA$0.08517.1% of flowCommon SharesTSXSEDI:2775275
Canonical exit: 30 Mar 2016 (T+90)
18,728 shares@ CA$0.0782.9% of flowCommon SharesTSXSEDI:2775274
Canonical exit: 30 Mar 2016 (T+90)
19 of 19 declarations
About Med BioGene Inc.
Med BioGene Inc. is a biotechnology company focused on developing diagnostic tests for cancer. It is listed on the Toronto Stock Exchange under the symbol XTSE.
